CPhI Istanbul Cements Rapid Pharma Sector Growth in Eurasia, Central Asia and MENA Regions - WDAM - TV 7 - News, Weather and Sports

CPhI Istanbul Cements Rapid Pharma Sector Growth in Eurasia, Central Asia and MENA Regions

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE UBM Live

ISTANBUL, June 26, 2014 /PRNewswire/ --

Successful first edition facilitates international partnerships and continued domestic manufacturing growth 

 

Leading events organiser, UBM Live, announces the successful launch of CPhI Istanbul 2014, which took place on June 4th-6th 2014 at the Lutfi Kirdar International Convention and Exhibition Centre in Istanbul.

     (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

The event co-located with P-MEC, InnoPack and ICSE, providing an unrivalled meeting point for bringing together senior pharma professionals and international pharmaceutical suppliers and buyers of pharma raw materials, machinery, packaging solutions and contract services.

Strategically partnered with the Pharmaceutical Manufacturers Association of Turkey (IEIS), CPhI Istanbul attracted over 4,000 attendees, both local and international.

The Official CPhI Istanbul Conference was a great success. The Conference room was fully packed with delegates and press who listened to prominent speakers of the Opening Keynote Theatre. Key trends in the Turkish pharmaceutical market were discussed by thought leaders of the industry such as Turgut Tokgoz, Secretary General of IEIS and Dr.Saim Kerman, President of the Turkey Pharmaceuticals and Medical Devices Agency. This year's focus covered opportunities for generics, supergenerics, biosimilars and establishing Turkey as the manufacturing hub of the region. The conference alo included updates on the Middle East & North Africa market and the Russia, CIS and emerging markets.

CPhI Istanbul concluded with an overview of API sourcing strategies and successfull technology transfers to CMO partners. The quality of the presentations and sessions was extremely high, with positive feedback already received from industry delegates and visitors- having enhanced their experience on site with essential local knowledge and meeting future partners.

Hande Yilmaz, Marketing Manager, UBM Istanbul, commented: "As the seventh largest market in Europe, and 16th largest globally, Turkey is firmly placed on the pharmaceutical map. More and more companies are looking to break into what is a dynamic and reforming market and CPhI Istanbul provides the essential platform to facilitate this. The event successfully brought together both domestic and international buyers and suppliers and has, undoubtedly, contributed to the continued expansion of one of the fastest growing regions of the pharmaceutical industry. I very much look forward to returning for next year's event to provide an even bigger edition, particularly as the next few years are predicted to be a very exciting time for the Turkish pharma market."

The main sponsor of the International CPhI Istanbul 2014 event is Deva Ilac. The event is organized with the support of the Ministry of Health and the Pharmaceutical Manufacturers Association (IEIS). World Medicine, Infa Group, Oceanic Pharmachem, Koçak Farma, Pharmactive, Nobel, Mustafa Nevzat, Helba and Santa Farma are the corporate sponsors of the event.

The entrance fee collected during the show (from those visitors who did not pre-register) has been donated to the families of the Turkish citizens who died in the Soma incident in Turkey- 50TL per visitor, 6300TL was given in total. 

The UBM Live annual schedule of Pharmaceutical events also includes CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC- Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte- France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre- Tokyo). CPhI Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75, Moscow Russia); CPhI, P-MEC and Innopack South East Asia (26-28 May, 2015 at the Jakarta International Expo- Jakarta, Indonesia) CPhI Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey).

About CPhI 

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia, Istanbul and South America co-located with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com.

For more information visit: http://www.cphi.com

About UBM Live 

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis    
De Facto Communications
T: +44-207-203-6745/6740
E: a.heeley@defacto.com / t.jervis@defacto.com


©2012 PR Newswire. All Rights Reserved.